Hancom Lifecare Inc. (KRX:372910)
South Korea · Delayed Price · Currency is KRW 1,679.00
-6.00 (-0.36%)
At close: Jul 28, 2026
Hancom Lifecare Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 91,433 | 92,088 | 104,776 | 112,780 | 100,120 | 121,140 |
Revenue Growth | -6.49% | -12.11% | -7.10% | 12.64% | -17.35% | -20.22% |
Gross Profit Gross Profit Growth | 19,884 | 21,173 | 28,902 | 23,448 | 19,642 | 27,722 |
Operating Income Operating Income Growth | -6,961 | -6,578 | 7,416 | 1,832 | -1,423 | 4,781 |
Net Income Net Income Growth | -7,164 | -7,725 | 7,375 | 824.71 | 9,204 | 4,835 |
Earnings Per Share EPS Growth | -259.00 | -279.14 | 266.00 | 29.80 | 332.58 | 196.00 |
EPS Growth | - | - | 792.60% | -91.04% | 69.68% | -84.94% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
South Korea South Korea Growth | 88,398 | 88,734 | 103,338 | 108,558 | 95,296 | 117,373 |
Oversea Oversea Growth | 3,036 | 3,354 | 1,438 | 4,222 | 4,825 | 3,767 |
Total Total Growth | 91,433 | 92,088 | 104,776 | 112,780 | 100,120 | 121,140 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 35,991 | 51,366 | 34,412 | 16,600 | 59,430 | 62,608 |
Total Debt Total Debt Growth | 394.29 | 419.59 | 532.96 | 789.25 | 4,353 | 5,591 |
Net Cash (Debt) Net Cash Growth | 35,597 | 50,947 | 33,879 | 15,811 | 55,076 | 57,016 |
Net Cash Growth | 55.51% | 50.38% | 114.27% | -71.29% | -3.40% | - |
Net Cash Per Share Net Cash Per Share Growth | 1286.27 | 1840.94 | 1224.19 | 571.32 | 1990.16 | 2313.90 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,800 | 22,676 | 22,266 | -8,466 | 5,082 | 28,051 |
Capital Expenditures CapEx Growth | -5,149 | -5,715 | -4,103 | -5,084 | -5,764 | -9,225 |
Free Cash Flow Free Cash Flow Growth | 12,650 | 16,962 | 18,164 | -13,550 | -681.63 | 18,826 |
Free Cash Flow Growth | -13.95% | -6.62% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 21.75% | 22.99% | 27.58% | 20.79% | 19.62% | 22.88% |
Operating Margin | -7.61% | -7.14% | 7.08% | 1.62% | -1.42% | 3.95% |
Pretax Margin | -9.27% | -10.18% | 8.67% | 1.44% | 13.22% | 4.62% |
Profit Margin | -7.83% | -8.39% | 7.04% | 0.73% | 9.19% | 3.99% |
FCF Margin | 13.84% | 18.42% | 17.34% | -12.01% | -0.68% | 15.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 11.78 | 152.18 | 17.59 | 50.77 |
Forward PE | 12.06 | 11.39 | 10.40 | - | - | - |
P/FCF Ratio | 3.67 | 4.92 | 4.78 | - | - | 13.04 |
PS Ratio | 0.51 | 0.91 | 0.83 | 1.11 | 1.62 | 2.03 |